Advances in Inflammatory Bowel Diseases, Crohn’s & Colitis Foundation’s Clinical & Research Conference is Moving to Orlando in 2014

Share Article

2014 Relocation to Accommodate for Growth and Expanded Content Offerings

Our aim is to keep the professional yet intimate and personal feel of the conference, but to alleviate overcrowding and accommodate for growth. This move to Orlando will allow for that." - Dr. Stephen B. Hanauer, conference co-chair

The Crohn’s & Colitis Foundation of America (CCFA) and Imedex are pleased to announce that the 2014 “can’t miss” event for healthcare professionals and researchers who study and manage patients with inflammatory bowel diseases (IBD) will be moving to its new location, Orlando, FL.

Though the conference has been held in Hollywood, FL for many years, its ever-expanding audience has necessitated a move. “We’ve simply outgrown our existing space and want to ensure the experience and quality of the event remains intact,” said conference co-chair Dr. Stephen B. Hanauer. “Our aim is to keep the professional yet intimate and personal feel of the conference, but to alleviate overcrowding and accommodate for growth. This move to Orlando will allow for that, and bring greater opportunities to expand the content and offerings.”

The conference will again be held over three days, and offer a two-track format designed for clinicians, researchers, allied health professionals, nurses, and pediatric gastroenterologists. Expanded Meet-the-Experts sessions, increased symposia, larger presentation rooms, and networking event space will all benefit from the relocation.

Co-chaired by Richard P. MacDermott, MD, MACG, FACP, AGAF and Stephen B. Hanauer, MD, FACG, AGAF, the conference will take place on December 4-6, 2014 at the Hilton Orlando in Orlando, FL. More information will be available in early 2014 at http://www.advancesinibd.com.

About the Crohn's & Colitis Foundation
The Crohn's & Colitis Foundation of America (CCFA) is the largest voluntary non-profit health organization dedicated to finding cures for Inflammatory Bowel Diseases (IBD). CCFA’s mission is to cure Crohn's disease and ulcerative colitis, and to improve the quality of life of children and adults who suffer from these diseases. The Foundation works to fulfill its mission by funding research, providing educational resources for patients and their families, medical professionals, and the public, and furnishing supportive services for those afflicted with IBD. For more information, visit http://www.ccfa.org, call 888-694-8872, like us on Facebook, or follow us on Twitter.

About Imedex®
Imedex is an industry leader in providing accredited, independent continuing medical education to health care professionals. We develop high quality scientific programming that translates the latest research into clinically relevant information. The activities have exceptional organization and outstanding educational value, with a proven sustained impact on disease management.

Our programs focus on improving patient care around the world. With over 50,000 e-learning experiences annually and more than 100,000 live meeting attendees since 2001, Imedex truly educates the global healthcare community. At Imedex, education is the best medicine.®

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Carlton Sanderson

770-751-7332
Email >
Visit website